ClinVar Miner

Submissions for variant NM_006231.4(POLE):c.1287G>T (p.Lys429Asn)

dbSNP: rs1593073300
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001010770 SCV001171010 uncertain significance Hereditary cancer-predisposing syndrome 2019-09-16 criteria provided, single submitter clinical testing The p.K429N variant (also known as c.1287G>T), located in coding exon 13 of the POLE gene, results from a G to T substitution at nucleotide position 1287. The lysine at codon 429 is replaced by asparagine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.